Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Save citation to file Format: Email citation To: Subject: Body: Format: Add to Collections Create a new collection Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Add to My Bibliography My Bibliography Your saved search Name of saved search: Search terms: Email: (change) Frequency: Which day? Which day?
Specialty therapies are increasingly being self-administered, requiring patients and caregivers to have a thorough understanding of reconstituting and injecting these medications. This study measures treatment adherence evaluated by the use of a patient activation measure (PAM) and administration comfortability of C1 esterase inhibitor therapy for hereditary angioedema patients.
Achieving healthcare quality improvements and cost reduction necessitates the participation of activated and informed consumers and patients. Identifying factors leading to low patient activation could help optimize interventions to increase the quality of healthcare. This study attempted to identify predictors of low patient activation measures (PAMs) among patients initiating C1 esterase inhibitor (recombinant) (C1-INH) for the treatment of hereditary angioedema.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
